Morgan Stanley analyst Matthew Harrison maintained a Hold rating on Gilead Sciences (GILD – Research Report) today and set a price target ...

The global hepatitis B diagnostic tests market is on the brink of significant expansion, driven by a surge in disease incidence, heightened awareness campaigns, and rapid advancements in diagnostic ...

Analyst Michael Yee from Jefferies maintained a Buy rating on Gilead Sciences (GILD – Research Report) and keeping the price target at ...

Punjab Chief Minister Bhagwant Mann on Saturday tested positive for leptospirosis, a bacterial infection. Doctors said that ...

The risk of human immunodeficiency virus (HIV), a virus that can be a sexually transmitted infection (STI), is quite high during unprotected anal sex (penetrating the rectum). The anal sex risk is ...

The plaintiffs claim Teva struck deals to settle patent suits with Gilead that delayed the introduction of a generic form of Viread until December 2017 and generic forms of Truvada and Atripla until ...